NuCana PLC (NCNA)
1.24
-0.03
(-2.36%)
USD |
NASDAQ |
Nov 22, 11:43
NuCana Total Assets (Quarterly): 25.38M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 25.38M |
March 31, 2024 | 31.31M |
December 31, 2023 | 35.43M |
September 30, 2023 | 41.44M |
June 30, 2023 | 52.04M |
March 31, 2023 | 60.38M |
December 31, 2022 | 70.50M |
September 30, 2022 | 76.67M |
June 30, 2022 | 80.82M |
March 31, 2022 | 93.82M |
December 31, 2021 | 104.56M |
September 30, 2021 | 120.55M |
June 30, 2021 | 127.78M |
March 31, 2021 | 138.65M |
December 31, 2020 | 146.90M |
Date | Value |
---|---|
September 30, 2020 | 154.22M |
June 30, 2020 | 78.90M |
March 31, 2020 | 82.87M |
December 31, 2019 | 92.13M |
September 30, 2019 | 93.35M |
June 30, 2019 | 101.37M |
March 31, 2019 | 107.25M |
December 31, 2018 | 110.63M |
September 30, 2018 | 117.40M |
June 30, 2018 | 118.81M |
March 31, 2018 | 126.09M |
December 31, 2017 | 130.21M |
June 30, 2017 | 30.76M |
December 31, 2016 | 33.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.38M
Minimum
Jun 2024
154.22M
Maximum
Sep 2020
84.97M
Average
80.82M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 317.44M |
Biodexa Pharmaceuticals PLC | 17.67M |
Autolus Therapeutics PLC | 827.49M |
Mereo BioPharma Group PLC | 88.75M |
Bicycle Therapeutics PLC | 996.75M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 20.58M |
Shareholders Equity (Quarterly) | 4.806M |